682887868	682887868	CD	B-NP	O
|	|	NN	I-NP	O
CLH	CLH	NN	I-NP	O
|	|	NN	I-NP	O
08331361	08331361	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3231849	3231849	CD	B-NP	O
|	|	CC	I-NP	O
4/24/2007	4/24/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
chf	chf	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/22/2007	2/22/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/25/2007	9/25/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
SHAULL	SHAULL	NN	B-NP	O
,	,	,	O	O
DARIN	DARIN	NN	B-NP	O
997-26-20-6	997-26-20-6	CD	I-NP	O
Ton	Ton	NNP	I-NP	O
-	-	HYPH	I-NP	O
Ph	Ph	NNP	I-NP	O
Aga	Aga	NNP	I-NP	O
Van	Van	NNP	I-NP	O
Ux	Ux	NNP	I-NP	O
Ny	Ny	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/3/07	8/3/07	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HEINIGER	HEINIGER	NNP	B-NP	O
,	,	,	O	O
DARRON	DARRON	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/12/07	10/12/07	CD	B-NP	O
by	by	IN	B-PP	O
LAUB	LAUB	NN	B-NP	B-protein
,	,	,	O	O
STERLING	STERLING	VBG	B-VP	O
B	B	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
154604536	154604536	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/4/07	2/4/07	CD	B-NP	O
by	by	IN	B-PP	O
KRABBE	KRABBE	NNP	B-NP	O
,	,	,	O	O
TERRY	TERRY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
962016810	962016810	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
37.5	37.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
CAPTOPRIL	CAPTOPRIL	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/28/07	4/28/07	CD	B-NP	O
by	by	IN	B-PP	O
CUCCHIARA	CUCCHIARA	NN	B-NP	O
,	,	,	O	O
JERROLD	JERROLD	NN	B-NP	B-protein
T	T	NN	I-NP	I-protein
CURTIS	CURTIS	NN	I-NP	I-protein
REYNALDO	REYNALDO	NN	I-NP	I-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
277572275	277572275	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
CELEXA	CELEXA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PLAVIX	PLAVIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
EPLERENONE	EPLERENONE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/28/07	4/28/07	CD	B-NP	O
by	by	IN	B-PP	O
HOEGERL	HOEGERL	NNP	B-NP	O
,	,	,	O	O
ISAAC	ISAAC	NNP	B-NP	O
E	E	NNP	I-NP	O
EDGAR	EDGAR	NNP	I-NP	O
CHESTER	CHESTER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
277572275	277572275	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
EPLERENONE	EPLERENONE	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
FOLATE	FOLATE	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
AT	AT	NNP	I-NP	O
5	5	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
1/6	1/6	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/12/07	10/12/07	CD	B-NP	O
by	by	IN	B-PP	O
GOODWINE	GOODWINE	NNP	B-NP	O
,	,	,	O	O
BUFORD	BUFORD	NNP	B-NP	O
H	H	NNP	I-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
262834677	262834677	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
TAMSULOSIN	TAMSULOSIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Genital	Genital	JJ	B-NP	O
ache	ache	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	B-DNA
NEURONTIN	NEURONTIN	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
GABAPENTIN	GABAPENTIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
TID	TID	NNP	I-NP	I-DNA
LORAZEPAM	LORAZEPAM	NNP	I-NP	I-DNA
0.5	0.5	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
PRN	PRN	NNP	I-NP	I-DNA
Anxiety	Anxiety	NNP	I-NP	I-DNA
LOVASTATIN	LOVASTATIN	NNP	I-NP	I-DNA
40	40	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/12/07	10/12/07	CD	B-NP	O
by	by	IN	B-PP	O
PERAULT	PERAULT	NNP	B-NP	O
,	,	,	O	O
SHELBY	SHELBY	NNP	B-NP	O
H	H	NNP	I-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
154604536	154604536	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LOVASTATIN	LOVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/4/07	2/4/07	CD	B-NP	O
by	by	IN	B-PP	O
KATSUDA	KATSUDA	NNP	B-NP	O
,	,	,	O	O
CLINTON	CLINTON	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
962016810	962016810	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LOVASTATIN	LOVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/22/07	8/22/07	CD	B-NP	O
by	by	IN	B-PP	O
OGIAMIEN	OGIAMIEN	NNP	B-NP	O
,	,	,	O	O
JACINTO	JACINTO	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LOVASTATIN	LOVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
051732183	051732183	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
leg	leg	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/22/07	8/22/07	CD	B-NP	O
by	by	IN	B-PP	O
TUROMSHA	TUROMSHA	NNP	B-NP	O
,	,	,	O	O
IRA	IRA	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
LOVASTATIN	LOVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
7	7	CD	B-NP	O
OMEPRAZOLE	OMEPRAZOLE	NN	I-NP	O
20	20	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
TEMAZEPAM	TEMAZEPAM	NNP	I-NP	O
15-30	15-30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Insomnia	Insomnia	NNP	I-NP	O
MULTIVITAMIN	MULTIVITAMIN	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	O
MULTIVI	MULTIVI	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/22/07	8/22/07	CD	B-NP	O
by	by	IN	B-PP	O
VANSTEENBURG	VANSTEENBURG	NNP	B-NP	O
,	,	,	O	O
TREVOR	TREVOR	NNP	B-NP	O
B	B	NNP	I-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LOVASTATIN	LOVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
051732183	051732183	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
LOVASTATIN	LOVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COSOPT	COSOPT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TIMOLOL/DORZOLAMIDE	TIMOLOL/DORZOLAMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
DROP	DROP	NNP	I-NP	O
OU	OU	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/22/07	8/22/07	CD	B-NP	O
by	by	IN	B-PP	O
LUTHY	LUTHY	NNP	B-NP	O
,	,	,	O	O
LANNY	LANNY	NNP	B-NP	O
D	D	NNP	I-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COSOPT	COSOPT	NN	B-NP	O
OU	OU	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
510463406	510463406	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
TAMSULOSIN	TAMSULOSIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Genital	Genital	JJ	B-NP	O
ache	ache	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
,	,	,	I-NP	O
home	home	NN	I-NP	O
med	me	VBD	B-VP	O
COUMADIN	COUMADIN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
1mg	1mg	CD	B-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
monday	monday	NN	B-NP	O
when	when	WRB	B-ADVP	O
you	you	PRP	B-NP	O
take	take	VBP	B-VP	O
2mg	2mg	NN	B-NP	O
,	,	,	O	O
unless	unless	IN	B-SBAR	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
AWMH	AWMH	NN	I-NP	O
tells	tell	VBZ	B-VP	O
you	you	PRP	B-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Food/Drug	Food/Drug	NN	B-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/12/07	10/12/07	CD	B-NP	O
by	by	IN	B-PP	O
ANGELILLO	ANGELILLO	NNP	B-NP	O
,	,	,	O	O
ORVILLE	ORVILLE	NNP	B-NP	O
R	R	NNP	I-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LOVASTATIN	LOVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TRAVATAN	TRAVATAN	NN	I-NP	O
1	1	CD	I-NP	O
DROP	DROP	NN	I-NP	O
OU	OU	NN	I-NP	O
BEDTIME	BEDTIME	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
OU	OU	NN	B-NP	O
.	.	.	O	O

thanks	thank	NNS	B-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Vonfelden	Vonfelden	NNP	I-NP	O
6/12	6/12	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Odien	Odien	NNP	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	O
051-469-9935	051-469-9935	CD	I-NP	O
for	for	IN	B-PP	O
earlier	early	JJR	B-NP	O
appointment	appointment	NN	I-NP	O
if	if	IN	B-SBAR	O
able	able	JJ	B-ADJP	O
.	.	.	O	O

2/23	2/23	CD	B-NP	O
@	@	NN	I-NP	O
3	3	CD	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
5/28/07	5/28/07	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
SUH	SUH	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
PREDNISONE	PREDNISONE	NN	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
TAMSULOSIN	TAMSULOSIN	NN	B-NP	B-protein
,	,	,	O	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	B-protein
,	,	,	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	B-NP	O
,	,	,	O	O
Fam	Fam	NNP	B-NP	O
Hx	Hx	NNP	I-NP	O
malignant	malignant	JJ	I-NP	O
hyperthermia	hyperthermia	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chf	chf	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chf	chf	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
kidney	kidney	NN	I-NP	O
stone	stone	NN	I-NP	O
cardiomyopathy-ef25	cardiomyopathy-ef25	CD	B-NP	O
%	%	NN	I-NP	O
degenerative	degenerative	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
blurred	blur	VBD	B-VP	O
vision	vision	NN	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
MI	MI	NN	B-NP	O
spinal	spinal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
spinal	spinal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
barrett	barrett	NN	I-NP	O
's	's	POS	B-NP	O
esophagus	esophagus	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
barrett	barrett	NN	I-NP	O
's	's	POS	B-NP	O
esophagus	esophagus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
glaucoma	glaucoma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
RHC/LHC	RHC/LHC	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
:	:	:	O	O
Wickell	Wickell	NNP	B-NP	O
,	,	,	O	O
Hyman	Hyman	NNP	B-NP	O
CARDS	CARDS	NNP	I-NP	O
:	:	:	O	O
Shannon	Shannon	NNP	B-NP	O
Marlon	Marlon	NNP	I-NP	O
Sefcik	Sefcik	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
78	78	CD	B-NP	O
M	M	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
CAD	CAD	NN	I-NP	O
S	S	NN	I-NP	O
/	/	SYM	B-VP	O
P	P	NN	B-NP	O
stents	stent	NNS	I-NP	O
-LRB-	-LRB-	NNP	B-NP	O
Cypher	Cypher	NNP	I-NP	O
to	to	TO	B-PP	O
LM	LM	NN	B-NP	O
and	and	CC	I-NP	O
LAD	LAD	NN	I-NP	O
in	in	IN	B-PP	O
10/25	10/25	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
CM	CM	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
S/P	S/P	NN	B-NP	O
AV	AV	NN	I-NP	O
node	node	NN	I-NP	O
ablation	ablation	NN	I-NP	O
4/3	4/3	CD	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
BiV	BiV	NN	I-NP	O
pacer	pacer	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
MGUS	MGUS	NN	B-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
syncope	syncope	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
orthostasis/dehydration	orthostasis/dehydration	NN	B-NP	B-protein
presenting	present	VBG	B-VP	I-protein
w.	w.	NN	B-NP	I-protein
SOB	SOB	NN	I-NP	I-protein
.	.	.	O	O

Usually	Usually	RB	B-ADVP	O
does	do	VBZ	B-VP	O
30	30	CD	B-NP	O
mins	min	NNS	I-NP	O
on	on	IN	B-PP	O
bike	bike	NN	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
having	have	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
with	with	IN	B-PP	O
20	20	CD	B-NP	O
mins	min	NNS	I-NP	O
,	,	,	O	O
stopping	stop	VBG	B-VP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
flight	flight	NN	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
,	,	,	O	O
used	use	VBN	B-VP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
2	2	CD	B-NP	O
flights	flight	NNS	I-NP	O
.	.	.	O	O

Sx	Sx	NN	B-NP	O
progressively	progressively	RB	B-VP	O
worsening	worsen	VBG	I-VP	O
over	over	IN	B-PP	O
past	past	JJ	B-NP	B-protein
1-2	1-2	CD	I-NP	I-protein
mos	mo	NNS	I-NP	I-protein
.	.	.	O	O

Weight	Weight	NN	B-NP	O
195	195	CD	I-NP	O
lbs	lb	NNS	I-NP	O
,	,	,	O	O
got	get	VBD	B-VP	O
extra	extra	JJ	B-NP	O
lasix	lasix	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
190	190	CD	B-NP	O
lb	lb	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
he	he	PRP	B-NP	O
says	say	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
noticed	notice	VBN	I-VP	O
difference	difference	NN	B-NP	O
in	in	IN	B-PP	O
sx	sx	NN	B-NP	O
.	.	.	O	O

+	+	SYM	O	O
CP	CP	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
treadmill	treadmill	NN	B-NP	O
,	,	,	O	O
stopped	stop	VBD	B-VP	O
with	with	IN	B-PP	O
resting	rest	VBG	B-NP	O
.	.	.	O	O

+	+	SYM	O	O
dizzy	dizzy	NN	B-NP	O
and	and	CC	I-NP	O
lightheadedness	lightheadedness	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
chronic	chronic	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
orthopena	orthopena	NN	I-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
edema.No	edema.No	NN	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
diet	diet	NN	B-NP	O
.	.	.	O	O

Taking	Take	VBG	B-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
PMHx	PMHx	NN	I-NP	O
:	:	:	O	O
ischemic	ischemic	JJ	B-NP	O
CM	CM	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
-20	-20	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dry	dry	JJ	I-NP	O
wt	wt	NN	I-NP	O
per	per	IN	B-PP	O
D/C	D/C	NN	B-NP	O
summary	summary	NN	I-NP	O
185.2	185.2	CD	I-NP	O
lb	lb	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	B-protein
Afib	Afib	NN	I-NP	I-protein
and	and	CC	O	O
VT	VT	NN	B-NP	O
,	,	,	O	O
S/P	S/P	NN	B-NP	B-protein
ICD	ICD	NN	I-NP	I-protein
7/1	7/1	CD	I-NP	I-protein
,	,	,	O	O
BiV	BiV	NN	B-NP	O
9/18	9/18	CD	I-NP	O
,	,	,	O	O
AV	AV	NN	B-NP	B-protein
node	node	NN	I-NP	I-protein
ablation	ablation	NN	I-NP	I-protein
11/26	11/26	CD	I-NP	I-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	O
S/P	S/P	NN	I-NP	O
IMI	IMI	NN	I-NP	O
1982	1982	CD	B-NP	O
stents	stent	NNS	I-NP	O
to	to	TO	B-PP	O
LM	LM	NN	B-NP	O
and	and	CC	I-NP	O
LAD	LAD	NN	I-NP	O
10/25	10/25	CD	I-NP	O
as	as	IN	B-PP	O
not	not	RB	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
CABG	CABG	NN	B-NP	B-protein
,	,	,	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
sleep	sleep	VB	B-VP	O
apnea	apnea	NNP	B-NP	O
,	,	,	O	O
DJD	DJD	NNP	B-NP	O
,	,	,	O	O
Barrett	Barrett	NNP	B-NP	O
's	's	POS	B-NP	O
esophagus	esophagus	NN	I-NP	O
,	,	,	O	O
Glaucoma	Glaucoma	NN	B-NP	O
,	,	,	O	O
Graves	Graves	NN	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
Diverticulitis	Diverticulitis	NN	B-NP	O
,	,	,	O	O
Hypothyroidism	Hypothyroidism	NN	B-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
,	,	,	O	O
Peripheral	Peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
restless	restless	JJ	B-NP	O
legs	leg	NNS	I-NP	O
,	,	,	O	O
Spinal	Spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

ALL	ALL	NN	B-NP	O
:	:	:	O	O
Prednisone	Prednisone	NN	B-NP	O
-	-	HYPH	O	O
>	>	SYM	O	O
soreness	soreness	NN	B-NP	O
,	,	,	O	O
PCN	PCN	NN	B-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	O	O
flushing	flushing	NN	B-NP	O
,	,	,	O	O
Tamsulosin	Tamsulosin	NN	B-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
genital	genital	JJ	I-NP	O
ache	ache	NN	I-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
gynecomastia	gynecomastia	NN	I-NP	O
.	.	.	O	O

Exam	Exam	NN	B-NP	O
:	:	:	O	O
95.7	95.7	CD	B-NP	O
8598/70	8598/70	CD	I-NP	O
absent	absent	JJ	I-NP	O
overshoot	overshoot	NN	I-NP	O
on	on	IN	B-PP	O
valsalva	valsalva	NN	B-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
well-appearing	well-appearing	JJ	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
distant	distant	JJ	B-NP	O
HS	HS	NN	I-NP	O
,	,	,	O	O
non-palpable	non-palpable	JJ	B-NP	O
PMI	PMI	NN	I-NP	O
,	,	,	O	O
diminished	diminish	VBN	B-NP	O
carotid	carotid	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
cm	cm	NN	I-NP	O
LUNGS	LUNGS	NN	I-NP	O
:	:	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
Abd	Abd	NN	I-NP	O
:	:	:	O	O
benign	benign	JJ	B-NP	O
,	,	,	I-NP	O
non-pulsatile	non-pulsatile	JJ	I-NP	O
liver	liver	NN	I-NP	O
Ext	Ext	NN	I-NP	O
:	:	:	O	O
cool	cool	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
PT	PT	NN	I-NP	O
B/L	B/L	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
Neuro	Neuro	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
facial	facial	JJ	I-NP	O
droop	droop	NN	I-NP	O
,	,	,	O	O
non-focal	non-focal	JJ	B-NP	O
***	***	SYM	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
neg	neg	NN	B-NP	O
Stress	Stress	NNP	I-NP	O
Echo	Echo	NNP	I-NP	O
8/17/06	8/17/06	CD	I-NP	O
:	:	:	O	O
66	66	CD	B-NP	O
%	%	NN	I-NP	O
MPHR	MPHR	NN	I-NP	O
,	,	,	O	O
RPP	RPP	NN	B-NP	B-protein
12000	12000	CD	I-NP	I-protein
BPM	BPM	NN	I-NP	I-protein
,	,	,	O	O
stopped	stop	VBD	B-VP	O
for	for	IN	B-PP	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
.	.	.	O	O

LV	LV	NN	B-NP	O
enlarged	enlarge	VBD	B-VP	O
.	.	.	O	O

EF	EF	NN	B-NP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
RWMA	RWMA	NN	I-NP	O
,	,	,	O	O
mid	mid	JJ	B-NP	O
and	and	CC	I-NP	O
distal	distal	JJ	I-NP	O
ant	ant	JJ	I-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
mid	mid	JJ	B-NP	O
and	and	CC	I-NP	O
distal	distal	JJ	I-NP	O
ant	ant	JJ	I-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
inf	inf	NN	B-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
entire	entire	JJ	B-NP	O
apex	apex	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
post	post	NN	B-NP	O
wall	wall	NN	I-NP	O
AK	AK	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
other	other	JJ	I-NP	O
walls	wall	NNS	I-NP	O
HK	HK	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
stress	stress	NN	B-NP	O
:	:	:	O	O
LV	LV	NN	B-NP	O
not	not	RB	B-VP	O
dilated	dilate	VBN	I-VP	O
.	.	.	O	O

akinetic	akinetic	JJ	B-NP	O
segments	segment	NNS	I-NP	O
remained	remain	VBD	B-VP	O
so	so	RB	B-ADVP	O
.	.	.	O	O

EF	EF	NN	B-NP	B-protein
up	up	IN	B-NP	O
to	to	TO	I-NP	O
25	25	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

ETT	ETT	NN	B-NP	B-DNA
8/17/06	8/17/06	CD	I-NP	I-DNA
:	:	:	O	O
STANDARD	STANDARD	NN	B-NP	O
BRUCE	BRUCE	NN	I-NP	O
,	,	,	O	O
stopped	stop	VBD	B-VP	O
for	for	IN	B-PP	O
DYSPNEA	DYSPNEA	NNP	B-NP	O
&	&	CC	I-NP	O
FATIGUE	FATIGUE	NNP	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
'	'	SYM	I-NP	O
16	16	CD	I-NP	O
''	''	''	O	O
,	,	,	O	O
57.74	57.74	CD	B-NP	O
%	%	NN	I-NP	O
MPHR	MPHR	NN	I-NP	O
,	,	,	O	O
RPP	RPP	NN	B-NP	B-DNA
8200	8200	CD	I-NP	I-DNA
,	,	,	O	O
no	no	DT	B-NP	O
ectopy	ectopy	NN	I-NP	O
.	.	.	O	O

Cath	Cath	NNP	B-NP	O
9/22	9/22	CD	I-NP	O
Right	Right	NNP	I-NP	O
Dominant	Dominant	NNP	I-NP	O
,	,	,	O	O
LM	LM	NNP	B-NP	O
ostial	ostial	JJ	I-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
prox	prox	NN	B-NP	O
LAD	LAD	NN	I-NP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
both	both	DT	B-NP	O
got	get	VBD	B-VP	O
Cyphers	Cypher	NNPS	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
RAS	RAS	NN	I-NP	B-protein
.	.	.	O	O

RCA	RCA	NN	B-NP	B-protein
not	not	RB	B-VP	O
evaluated	evaluate	VBN	I-VP	O
.	.	.	O	O

Cath	Cath	NN	B-NP	B-protein
7/9	7/9	CD	I-NP	I-protein
RCA	RCA	NN	I-NP	I-protein
evaluated	evaluate	VBD	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
Mid	Mid	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
RCA	RCA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
Proximal	Proximal	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Elevated	Elevated	JJ	B-NP	O
RH	RH	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

PFTs	PFT	NNS	B-NP	O
3/30/92	3/30/92	CD	B-NP	O
:	:	:	O	O
FEV1	FEV1	CD	B-NP	O
101	101	CD	I-NP	O
%	%	NN	I-NP	O
ADENOSINE	ADENOSINE	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
8/18/07	8/18/07	CD	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Abnormal	Abnormal	JJ	B-NP	O
and	and	CC	I-NP	O
consistent	consistent	JJ	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	B-protein
scar	scar	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
posterolateral/OM	posterolateral/OM	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
without	without	IN	B-PP	O
residual	residual	JJ	B-NP	O
adenosine	adenosine	NN	I-NP	O
induced	induce	VBD	B-VP	O
perfusion	perfusion	NN	B-NP	O
defect	defect	NN	I-NP	O
.	.	.	O	O

Test	Test	JJ	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
for	for	IN	B-PP	O
detecting	detect	VBG	B-VP	O
ischemia	ischemia	NN	B-NP	O
is	be	VBZ	B-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
separate	separate	JJ	I-NP	O
normally	normally	RB	I-NP	O
perfused	perfuse	VBN	I-NP	O
myocardium	myocardium	NN	I-NP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
to	to	TO	B-PP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Severe	Severe	JJ	B-NP	O
global	global	JJ	I-NP	O
LV	LV	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
essentially	essentially	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
from	from	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
.	.	.	O	O

CATH	CATH	NN	B-NP	B-protein
8/11/07	8/11/07	CD	I-NP	I-protein
:	:	:	O	O
LHC	LHC	NN	B-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
dom	dom	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
LM	LM	NN	I-NP	O
or	or	CC	I-NP	O
LAD	LAD	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

Cx	Cx	NN	B-NP	O
with	with	IN	B-PP	O
discrete	discrete	JJ	B-NP	O
calcified	calcify	VBN	I-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	B-protein
with	with	IN	B-PP	O
porx	porx	NN	B-NP	O
diffuse	diffuse	JJ	I-NP	O
calcified	calcify	VBN	I-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
RT	RT	NN	B-NP	O
LV-BR	LV-BR	NN	I-NP	O
prox	prox	NN	I-NP	O
tubular	tubular	JJ	I-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
since	since	IN	B-PP	O
2005	2005	CD	B-NP	O
.	.	.	O	O

RHC	RHC	NN	B-NP	B-protein
:	:	:	O	O
RA	RA	NN	B-NP	O
7/8	7/8	CD	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
RV	RV	NN	I-NP	O
27/5	27/5	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
PA	PA	NN	I-NP	O
26/13	26/13	CD	I-NP	O
,	,	,	O	O
19	19	CD	B-NP	O
PCWP	PCWP	NN	I-NP	O
16	16	CD	B-NP	O
,	,	,	O	O
CO/CI	CO/CI	NN	B-NP	B-protein
3.6	3.6	CD	I-NP	I-protein
/	/	SYM	O	O
1.8	1.8	CD	B-NP	O
TTE	TTE	CD	I-NP	O
:	:	:	O	O
10/6/07	10/6/07	CD	B-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	B-protein
HK	HK	NN	I-NP	I-protein
and	and	CC	I-NP	O
ant/apical/inf	ant/apical/inf	NN	I-NP	O
/	/	SYM	B-NP	O
post/mid	post/mid	NN	I-NP	O
sept	sept	VBD	B-VP	O
AK	AK	NNP	B-NP	O
.	.	.	O	O

Severe	Severe	JJ	B-NP	O
decr	decr	NN	I-NP	O
RV	RV	NN	I-NP	O
fxn	fxn	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
LAE	LAE	NN	I-NP	O
,	,	,	O	O
Mild	Mild	NNP	B-NP	O
AR	AR	NNP	I-NP	O
,	,	,	O	O
Tr	Tr	NNP	B-NP	B-protein
TR/PR	TR/PR	NNP	I-NP	I-protein
,	,	,	O	O
Mod	Mod	NNP	B-NP	O
MR	MR	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	RB	B-ADVP	O
.	.	.	O	O

***	***	SYM	O	O
Hospital	Hospital	NN	B-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
78	78	CD	B-NP	O
M	M	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
iCM	iCM	NN	B-NP	O
EF	EF	NN	I-NP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Suspected	Suspect	VBN	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
-	-	HYPH	O	O
Checked	Check	VBN	B-NP	O
troponin	troponin	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
neg	neg	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
for	for	IN	B-PP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
ASA/Plavix	ASA/Plavix	NNP	I-NP	O
,	,	,	O	O
BB	BB	NNP	B-NP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
causing	cause	VBG	B-VP	O
his	his	PRP$	B-NP	B-DNA
worsening	worsen	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
so	so	RB	B-ADVP	O
Adenosine	Adenosine	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
on	on	IN	B-PP	O
6/26	6/26	CD	B-NP	O
w/o	w/o	NN	I-NP	O
focal	focal	JJ	I-NP	O
defects	defect	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
good	good	JJ	I-NP	O
area	area	NN	I-NP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
it	it	PRP	B-NP	O
to	to	TO	B-PP	O
.	.	.	O	O

LHC	LHC	NN	B-NP	O
w/o	w/o	NN	I-NP	O
new	new	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
interventions	intervention	NNS	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
nl	nl	NN	I-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
Possibly	Possibly	RB	B-VP	O
slightly	slightly	RB	I-VP	O
volume	volume	VB	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

RHC	RHC	NN	B-NP	B-protein
with	with	IN	B-PP	O
wedge	wedge	NN	B-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
.	.	.	O	O

Changed	Changed	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
Dig/nitrate/BB	Dig/nitrate/BB	NNP	I-NP	O
,	,	,	O	O
ACEi	ACEi	NNP	B-NP	O
.	.	.	O	O

Checked	Check	VBN	B-NP	O
echo	echo	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

Rhythym	Rhythym	NN	B-NP	O
:	:	:	O	O
Tele	Tele	NNP	B-NP	O
.	.	.	O	O

Lyte	Lyte	NN	B-NP	O
replete	replete	JJ	I-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
COPD	COPD	NN	I-NP	O
by	by	IN	B-PP	O
PFTs	PFT	NNS	B-NP	O
1992	1992	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
asthma	asthma	NN	I-NP	O
or	or	CC	I-NP	O
PNA	PNA	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
CRI	CRI	NN	B-NP	O
-LRB-	-LRB-	SYM	B-NP	O
1.4-1	1.4-1	CD	I-NP	O
.8	.8	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

1.6	1.6	CD	B-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
,	,	,	O	O
follow	follow	NN	B-NP	O
.	.	.	O	O

Stable	Stable	JJ	B-ADJP	O
,	,	,	O	O
got	get	VBD	B-VP	O
mucomyst	mucomyst	JJ	B-NP	O
pre	pre	JJ	I-NP	O
cath	cath	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bump	bump	NN	I-NP	O
in	in	IN	B-PP	O
Cr	Cr	NNP	B-NP	O
.	.	.	O	O

1.4	1.4	CD	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Barrett	Barrett	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
PPI	PPI	NN	I-NP	B-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
neuropathy	neuropathy	NN	B-NP	O
,	,	,	O	O
neurontin	neurontin	NN	B-NP	B-protein
,	,	,	O	O
celexa	celexa	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Optho	Optho	NNP	B-NP	O
:	:	:	O	O
glaucoma	glaucoma	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
eye	eye	NN	B-NP	O
drops	drop	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
FEN	FEN	NNP	I-NP	O
:	:	:	O	O
CV	CV	NNP	B-NP	O
,	,	,	O	O
NAS	NAS	NNP	B-NP	O
,	,	,	O	O
2L	2L	NN	B-NP	O
fluid	fluid	NN	I-NP	O
restrict	restrict	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
Held	Held	JJ	B-NP	O
coumadin	coumadin	NN	I-NP	O
for	for	IN	B-PP	O
cath	cath	NN	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
restarted	restart	VBD	B-VP	O
it	it	PRP	B-NP	O
with	with	IN	B-PP	O
2mg	2mg	NN	B-NP	O
on	on	IN	B-PP	O
1/16	1/16	CD	B-NP	O
,	,	,	I-NP	O
1mg	1mg	CD	I-NP	O
on	on	IN	B-PP	O
10/2	10/2	CD	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
stop	stop	VB	B-VP	O
taking	take	VBG	I-VP	O
your	your	PRP$	B-NP	O
Imdur	Imdur	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
measure	measure	VB	I-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
MD	MD	NN	I-NP	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
increases	increase	VBZ	B-VP	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
5lbs	5lb	NNS	B-NP	B-protein
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
or	or	CC	O	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2-3	2-3	CD	I-NP	O
lbs	lb	NNS	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	VB	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
and	and	CC	O	O
take	take	VB	B-VP	O
it	it	PRP	B-NP	O
as	as	RB	B-ADVP	O
previously	previously	RB	I-ADVP	O
.	.	.	O	O

Check	Check	VB	B-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
on	on	IN	B-PP	O
monday	monday	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
Lasix	Lasix	NNP	B-NP	O
60	60	CD	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
resume	resume	VB	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
volume	volume	NN	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
1.7	1.7	CD	B-NP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
check	check	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
on	on	IN	B-PP	O
5/28/07	5/28/07	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
GIPSON	GIPSON	NNP	B-NP	O
,	,	,	O	O
KOREY	KOREY	NNP	B-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
UY260	UY260	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/3/07	8/3/07	CD	I-NP	O
@	@	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
28	28	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

